Morphologic and flow cytometric features of menin inhibitor-induced pseudoprogression in KMT2A-rearranged acute myeloid leukemia.
Menin inhibitor therapy can mimic disease progression on imaging in leukemia—a pattern doctors should recognize to avoid unnecessary treatment changes.
This brief communication in Blood describes morphologic and flow cytometric features of pseudoprogression induced by menin inhibitor therapy in KMT2A-rearranged AML — a potentially important pitfall for clinicians to recognize during response assessment. No abstract text was available from PubMed; classification based on title and journal context.
What the study was
- Study design
- Case report or brief communication
- Population
- KMT2A-rearranged AML patients receiving menin inhibitor therapy
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Blood
Why it surfaced
Title-only; no abstract available. Cap applied: max score 3 for title-only records. Clinically relevant topic (menin inhibitors in KMT2A-AML are an active area) but cannot score higher without abstract review.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.